English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
The Oklahoma Proton Center LLC
Patient Daily
| Jun 10, 2025
Radiation oncologist on 340B program: ‘It is used as a consolidation tool by large institutions to kill competition in the market’
Trending
+
Pharmaceuticals
Patient Daily
| Jun 10, 2025
Radiation oncologist on 340B program: ‘It is used as a consolidation tool by large institutions to kill competition in the market’
+
Pharmaceuticals
Patient Daily
| Jun 9, 2025
Director of Public Affairs of PhRMA: ‘There is also evidence that 340B is harming state and federal budgets’
+
Pharmaceuticals
Patient Daily
| Jun 5, 2025
Exon 20 Group questions effectiveness of 340B drug program
+
Pharmaceuticals
Patient Daily
| Jun 4, 2025
American Lung Association offers guidance on Saharan dust impact on health
